Showing results (711-720 of 2,363) with videos related to
Sort By:
Pageof 237
Future Medicinal Chemistry|August 4, 2017
Activity of a novel protonophore against methicillin-resistant Staphylococcus aureusNagendran Tharmalingam, Elamparithi Jayamani, Rajmohan Rajamuthiah, et al.Future Medicinal Chemistry|August 4, 2017
Multiple target-centric strategy to tame inflammationGaganpreet Kaur, Om SilakariFuture Medicinal Chemistry|November 16, 2016
Design of chalcogen-containing norepinephrines: efficient GPx mimics and strong cytotoxic agents against HeLa cellsAzucena Marset, Paloma Begines, Óscar López, et al.Future Medicinal Chemistry|November 16, 2016
Design and synthesis of a new series of highly potent RAF kinase-inhibiting triarylpyrazole derivatives possessing antiproliferative activity against melanoma cellsMohammad Ashrafuddin Khan, Mohammed I El-Gamal, Hamadeh Tarazi, et al.Future Medicinal Chemistry|October 25, 2016
Liposomal drug delivery systems for targeted cancer therapy: is active targeting the best choice?Shaghayegh Fathi, Adegboyega K OyelereFuture Medicinal Chemistry|December 14, 2016
Pyridazinone: an attractive lead for anti-inflammatory and analgesic drug discoveryJyoti Singh, Deepika Sharma, Ranju BansalFuture Medicinal Chemistry|November 23, 2016
Zwitterionic structures: from physicochemical properties toward computer-aided drug designsZhiwei Yang, Qinyi Li, Gang YangFuture Medicinal Chemistry|March 22, 2014
Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinasesSandra W Cowan-Jacob, Wolfgang Jahnke, Stefan KnappFuture Medicinal Chemistry|March 22, 2014
Early repositioning through compound set enrichment analysis: a knowledge-recycling strategyGergely Temesi, Bence Bolgár, Adám Arany, et al.Future Medicinal Chemistry|January 28, 2017
Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure-activity relationship analysesThales Kronenberger, Leonardo Rander Asse, Carsten Wrenger, et al.Pageof 237